Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pollak

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
American Journal of Medical Genetics. Part A|September 11, 2023
Musculoskeletal phenotypes in 3q29 deletion syndromeRebecca M Pollak, Jacob C Tilmon, Melissa M Murphy, et al.
The American Journal of Cardiology|April 3, 2022
Characteristics and Outcomes After Transcatheter Aortic Valve Implantation in Immunocompromised PatientsAlexander Ghannam, S Michael Gharacholou, Colleen T Ball, et al.
Oncogene|September 20, 2006
Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesisB Liu, K-W Lee, M Anzo, et al.
Prostate Cancer and Prostatic Diseases|May 22, 2013
The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout miceK Takahara, N Ibuki, M Ghaffari, et al.
Medrxiv : the Preprint Server for Health Sciences|April 17, 2023
Musculoskeletal phenotypes in 3q29 deletion syndromeRebecca M Pollak, Jacob C Tilmon, Melissa M Murphy, et al.
British Journal of Cancer|March 15, 2012
Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up studyX Zhang, E L Giovannucci, K Wu, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2015
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)M Joerger, R H N van Schaik, M L Becker, et al.
Medical and Pediatric Oncology|January 1, 1991
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B studyN A Dawson, M E Costanza, A H Korzun, et al.
Clinical Nephrology|September 24, 2010
Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppressionM E Schachter, M Monahan, J Radhakrishnan, et al.
Prostate Cancer and Prostatic Diseases|August 25, 2010
Effect of intermittent fasting on prostate cancer tumor growth in a mouse modelJ A Thomas, J A Antonelli, J C Lloyd, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
American Journal of Medical Genetics. Part A|September 11, 2023
Musculoskeletal phenotypes in 3q29 deletion syndromeRebecca M Pollak, Jacob C Tilmon, Melissa M Murphy, et al.
The American Journal of Cardiology|April 3, 2022
Characteristics and Outcomes After Transcatheter Aortic Valve Implantation in Immunocompromised PatientsAlexander Ghannam, S Michael Gharacholou, Colleen T Ball, et al.
Oncogene|September 20, 2006
Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesisB Liu, K-W Lee, M Anzo, et al.
Prostate Cancer and Prostatic Diseases|May 22, 2013
The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout miceK Takahara, N Ibuki, M Ghaffari, et al.
Medrxiv : the Preprint Server for Health Sciences|April 17, 2023
Musculoskeletal phenotypes in 3q29 deletion syndromeRebecca M Pollak, Jacob C Tilmon, Melissa M Murphy, et al.
British Journal of Cancer|March 15, 2012
Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up studyX Zhang, E L Giovannucci, K Wu, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2015
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)M Joerger, R H N van Schaik, M L Becker, et al.
Medical and Pediatric Oncology|January 1, 1991
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B studyN A Dawson, M E Costanza, A H Korzun, et al.
Clinical Nephrology|September 24, 2010
Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppressionM E Schachter, M Monahan, J Radhakrishnan, et al.
Prostate Cancer and Prostatic Diseases|August 25, 2010
Effect of intermittent fasting on prostate cancer tumor growth in a mouse modelJ A Thomas, J A Antonelli, J C Lloyd, et al.
Pageof 25